People are running their own experiments with GLP-1s — with stunning results
Apple News Today 
Open in Hinto About this episode
<p>From <a href="https://podcasts.apple.com/us/podcast/apple-news-in-conversation/id1577591053?i=1000776173199"><em>Apple News In Conversation</em></a>: GLP-1 drugs like Ozempic and Wegovy are being taken by millions of Americans. These medications have been approved for treating diabetes, obesity, and a small number of other chronic conditions. But even as experts are still learning how the drugs work, many people have found that they help with other disorders — from addiction to brain fog to arthritis — where anecdotal evidence is promising but the formal research hasn’t caught up. <a href="https://www.juliabelluz.com/" target="_blank" rel="noopener noreferrer">Julia Belluz</a>, a contributing writer for the <em>New York Times</em> Opinion section and coauthor of <a href="https://books.apple.com/us/book/food-intelligence/id6739794014" target="_blank" rel="noopener noreferrer"><em>Food Intelligence</em></a>, joins <em>Apple News In Conversation</em> guest host David Greene to explain why what’s unfolding right now may be the largest uncontrolled drug experiment in modern history.</p>
Listen to this episode in English to learn English
Podcast episodes are one of the highest-density ways to absorb English at native pace. People are running their own experiments with GLP-1s — with stunning results from Apple News Today gives you natural dialogue, unscripted speech, and vocabulary that actually appears in real conversations.
In the Hinto app, every word in the transcript is tappable. Tap an unknown word, see the translation in your language instantly, and keep listening without breaking flow.
Episodes to Learn English
- The brutal reality check awaiting Democrats Nov 6, 2026
- How Trump’s electoral coalition fell apart Nov 5, 2026
- A seismic Democratic win breaks Trump's grip on power Nov 4, 2026
- Inside the decision team the country relies on for election results Nov 3, 2026
- A shock endorsement shakes up Michigan’s pivotal Senate race Nov 2, 2026
- Have chocolate companies quietly changed their recipes? Oct 31, 2026
- Inside the allegations that Democrats stacked Alaska’s ballot Oct 30, 2026
- Election Day is fast approaching. These are the races to watch. Oct 29, 2026
- Government corruption is animating voters. Texas shows why. Oct 28, 2026
- Anthropic warned that AI could end humanity. Now it’s racing to go public. Oct 27, 2026
- Trump’s and Obama’s dueling rallies in a crucial swing state Oct 26, 2026
- The strange new politics of the death penalty Oct 24, 2026
- The scramble to save the internet from a catastrophic threat Oct 23, 2026
- The billionaires behind the record midterm ad blitz Oct 22, 2026
- What’s behind the youth protests sweeping Europe? Oct 21, 2026
- Three world powers could decide Ukraine’s future. Kyiv won’t be in the room. Oct 20, 2026
- What’s really driving a long-shot push to break up Canada Oct 19, 2026
- Your biggest midterm questions, answered Oct 17, 2026
- Iran’s plan to sway the U.S. elections Oct 16, 2026
- Prices keep climbing. Frustrated voters may take it out on Republicans. Oct 15, 2026
- The scandals that forced Trump to oust Ambassador Guilfoyle Oct 14, 2026
- DHS agents search Ilhan Omar’s home — weeks before an election Oct 13, 2026
- Trump’s surprise deal with Putin sparks Republican outrage Oct 12, 2026
- The Cornell case exposes a dark reality about college culture Oct 10, 2026
- Why some Republicans are getting worried about Texas Oct 9, 2026
- Lawyers share Christa Pike’s first words since waking — and make her case in court Oct 8, 2026
- Tennessee failed to execute Christa Pike. Now she’s conscious. Oct 7, 2026
- The Cornell case puts New York’s consent laws in the spotlight Oct 6, 2026
- How a Boeing jet survived a nosedive at extreme speed Oct 5, 2026
- Americans want more kids. Here’s what’s stopping them. Oct 3, 2026
